The S&P/TSX Surges, the Loonie Plunges, and is This Company the Next Amgen?

Equities finally catch a bid in 2014.

| More on:
The Motley Fool

Canadian equities surged higher on Tuesday boosted by surging commodity prices and a weak Canadian dollar.

The S&P/TSX Composite Index (^OSPTX) ended the trading session up 101.40 points, or 0.75%, to 13,596. U.S. equities also rallied sharply higher with the broad based Dow Jones Industrials Average rallying 105.84 points, or 0.64%.

Energy issues led the S&P/TSX 60 higher. Canada’s largest energy companies Suncor (TSX:SU, NYSE:SU) and Imperial Oil (TSX:IMO) each finished the trading session higher by 1.61% and 1.30% respectively.

And cold weather in the United States put a big bid underneath natural gas prices. On the New York Mercantile Exchange, natural gas futures for delivery in February traded at US$4.374 per million British thermal units during U.S. trading, up 1.57%. Gas weighted names like Encana (TSX:ECA, NYSE:ECA) and Talisman (TSX:TLM, NYSE:TLM) each finished up 0.64% and 2.38% respectively.

One piece of economic news that sent shares higher was Monday’s U.S. Senate confirmation of Janet Yellen as the next Federal Reserve chair. Yellen is an advocate of a more dovish monetary policy arguing that the central bank should do more to stimulate the country’s economic recovery. Such a policy would likely be bullish for equity prices.

Meanwhile, the Canadian dollar fell sharply on weak economic day down 1.10% to US$1.0773 – a three year low.

This way likely due to the nation’s merchandise trade deficit which widened to $940 million in November – nine times what economists had forecasted according to Bloomberg. The report is fueling doubt that the pickup in exports promised by the Bank of Canada will drive economic growth.

The Loonie extended losses later in the day after the Ivey’s Purchasing Manager’s Index fell to 46.3 in December, versus a reading of 53.7 in November. The index is based on a 100 point scale where a reading below 50 indicates a contraction in activity.

Here at Fool HQ, we’re not stressing about this type of macroeconomic volatility. While wild currency swings certainly affect our accounts day-to-day, over the long run these will roughly even out.

But today’s numbers do have some important takeaways. First, slow economic growth should kick a Bank of Canada rate hike down the road another six months or more. Second, investors with a home-bias in their portfolios are missing a big opportunity in the faster growing United States.

On the corporate side, shares of Valeant Pharmaceuticals (TSX:VRX, NYSE:VRX) surged 12.53% after the company announced that it’s looking to join the top five pharma companies in the world by market capitalization by 2016. During a conference call with analysts, Chief Executive Michael Pearson also predicted that the company’s revenue and cash earnings would increased 40% in 2014.

Valeant has earned the reputation of Canada’s ‘Little Johnson & Johnson’ after its remarkable run this past few years. The company’s winning formula has been to buy up small biotech firms and creating value by pushing these promising new drugs through its large distribution network.

This has been a great recipe for shareholders. Valeant shares have rallied 120% in the past year. And after this report, investors can likely expect those gains to continue in the New Year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Disclosure: Robert Baillieul has no positions in any of the stocks mentioned in this article.  

More on Investing

FREIGHT TRAIN
Investing

CNR Stock: Should You Buy Today?

Canadian National Railway has been hit in recent quarters, as economic growth has slowed, with CNR stock declining 10% in…

Read more »

Family relationship with bond and care
Dividend Stocks

TFSA Investors: 3 Cheap Canadian Stocks for Retirees

These three Canadian stocks are super cheap for retirees looking for a great buy that will last the test of…

Read more »

calculate and analyze stock
Dividend Stocks

CPP Disability Benefits: Here’s How Much You Could Get

Not everybody can get CPP disability benefits. If you want some passive income, consider investing in Royal Bank of Canada…

Read more »

growing plant shoots on stacked coins
Dividend Stocks

Boosting Your Monthly Income: TSX Stocks That Deliver

Dividend investing can boost regular or active incomes, especially select TSX stocks that pay monthly dividends.

Read more »

consider the options
Tech Stocks

Better Buy (2024 Edition): Shopify or Nvidia Stock?

Shopify (TSX:SHOP) isn't the only red-hot tech stock in town that could add to recent gains.

Read more »

Bad apple with good apples
Investing

5 Stocks You Can Confidently Invest $500 in Right Now

These stocks could significantly grow your investment over the next decade.

Read more »

Illustration of bull and bear
Tech Stocks

A Bull Market Is Coming: 3 Growth Stocks That Could Thrive

Given their high growth prospects and cheaper valuation, these three growth stocks would be an excellent buy as the market…

Read more »

Golden crown on a red velvet background
Energy Stocks

Enbridge Stock: This Dividend Aristocrat Could Gain in 2024

Enbridge (TSX:ENB) stock is looking like a great buy as management expects it to grow in 2024.

Read more »